The health sector had 21 companies reporting their quarterly earnings this week, with 18 of them beating profit estimates for the quarter. Quarter-To-Date, The Health Care Select Sector SPDR Fund ETF ...

Addressing a preliminary injunction in patent litigation related to the Biologics Price Competition and Innovation Act (BPCIA), the US Court ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

U.S. dairy cattle tested positive for a strain of bird flu that previously had not been seen in cows, the U.S. Department of ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Major stock indexes closed higher/lower on Friday, after the week saw a flurry of events including DeepSeek scare and ...

Government agencies have challenged J&J's bankruptcy proposal, which includes $8 Billion for around 60,000 asbestos ovarian cancer lawsuits.

Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...